Novo and Orsted Made Denmark Rich. Are the Boom Times Now Over?

At their heights, Denmark’s corporate champions seemed untouchable. Novo Nordisk A/S, long known mostly as an insulin maker, was Europe’s most valuable company last year, after riding a surge of demand for Ozempic and Wegovy. That followed the success of Orsted A/S, the world’s largest offshore wind...

Redirecting to full article...